GlobalData on MSN10d
ScreenPoint acquires Biomediq to bolster breast cancer risk assessment tool
With a decade-long collaboration history, the companies have previously demonstrated the value of their combined analysis ...
How Olivia Munn's cancer journey sparked life-saving test for Alison Hall
"Inside Edition" correspondent Alison Hall opens up about her breast cancer battle and how Olivia Munn's own experience with ...
ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment Capabilities
ScreenPoint Medical today announced the acquisition of Biomediq A/S, a research-based company focused on the research, ...
A Decade Younger: Why Indian Women Need Early Breast Cancer Screening
Apollo Hospitals offers a breast cancer risk assessment tool for Indian women to understand their risk and take proactive ...
PreludeDx Receives FDA Breakthrough Device Designation for DCISionRT® Test for DCIS Breast Cancer Patients
Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device ...
The American Journal of Managed Care7d
Identifying Patients With Low-Risk Breast Cancer for De-escalated Therapy
A new analysis of the Breast Cancer Index (BCI) may help identify women with HR-positive breast cancer who could potentially ...
Myriad Genetics Partners With Hannah Storm To Promote Breast Cancer Risk Assessment Program
Myriad Genetics Inc. (MYGN) announced an agreement with Hannah Storm, a nationally renowned sports broadcaster, who recently revealed ...
AIIMS devises new breast cancer detection tool: How AI and ASHA workers work together to map risk factors, help in early diagnosis
The goal is to collect vital data that can help AI tools identify breast cancer risk factors and patterns specific to Indian women. This initiative is part of an ambitious project by AIIMS Delhi aimed ...